TY  - JOUR
T1  - Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?
TT  - Is the presence of diffuse gastric hypermetabolism enough to exclude  a gastric tumour?
AU  - Özgüven, Salih
PY  - 2015
DA  - September
DO  - 10.5472/MMJ.2013.02828.1
JF  - Marmara Medical Journal
JO  - Marmara Med J
PB  - Marmara University
WT  - DergiPark
SN  - 1019-1941
SP  - 176
EP  - 177
VL  - 26
IS  - 3
LA  - en
AB  - Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?
CR  - Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
CR  - Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
CR  - Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
CR  - Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.
UR  - https://doi.org/10.5472/MMJ.2013.02828.1
L1  - https://dergipark.org.tr/en/download/article-file/2327
ER  -